{"id":"investigational-products-administration","safety":{"commonSideEffects":[{"rate":"null","effect":"Pneumonitis"},{"rate":"null","effect":"Hypothyroidism"},{"rate":"null","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL4525114","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action is not well understood, but it is believed to modulate the immune system by inhibiting the PD-1/PD-L1 interaction, leading to increased anti-tumor activity.","oneSentence":"This drug is an investigational product that targets the PD-1/PD-L1 pathway.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:16:54.079Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic non-small cell lung cancer, PD-L1 positive"},{"name":"Metastatic melanoma"}]},"trialDetails":[{"nctId":"NCT07498218","phase":"PHASE1","title":"Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue","status":"NOT_YET_RECRUITING","sponsor":"Ayu, Inc.","startDate":"2026-03-02","conditions":"Diabetic Foot Ulcer (DFU), Granulation of Chronic Diabetic Wounds","enrollment":24},{"nctId":"NCT03410992","phase":"PHASE3","title":"A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2018-02-05","conditions":"Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriatic Arthritis","enrollment":435},{"nctId":"NCT07464314","phase":"PHASE1","title":"A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2026-03-09","conditions":"Influenza, Human+COVID-19","enrollment":225},{"nctId":"NCT07330258","phase":"","title":"A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications","status":"RECRUITING","sponsor":"Bayer","startDate":"2026-03-31","conditions":"Parkinson's Disease","enrollment":300},{"nctId":"NCT07477366","phase":"PHASE2","title":"Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2026-04","conditions":"Relapsed B-Cell Non-Hodgkin Lymphoma","enrollment":20},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT07125872","phase":"PHASE2","title":"Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma","status":"RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2025-11-11","conditions":"Relapsed B-Cell Non Hodgkin Lymphoma","enrollment":20},{"nctId":"NCT06931652","phase":"PHASE2","title":"Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab","status":"RECRUITING","sponsor":"The Lymphoma Academic Research Organisation","startDate":"2025-09-22","conditions":"Primary CNS Lymphoma (PCNSL)","enrollment":60},{"nctId":"NCT07459946","phase":"NA","title":"Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence","status":"NOT_YET_RECRUITING","sponsor":"Jiazhen Yin","startDate":"2026-03-12","conditions":"Diabetic Nephropathy Type 2, Chronic Renal Failure/ Kidney Disease","enrollment":198},{"nctId":"NCT07445815","phase":"PHASE2","title":"A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody","status":"NOT_YET_RECRUITING","sponsor":"Lanzhou Institute of Biological Products Co., Ltd","startDate":"2026-01-31","conditions":"Rabies (Healthy Volunteers)","enrollment":200},{"nctId":"NCT05294588","phase":"PHASE2","title":"Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-04-18","conditions":"Gonorrhea Male","enrollment":65},{"nctId":"NCT07230288","phase":"PHASE2","title":"Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"AbbVie","startDate":"2026-01-23","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":165},{"nctId":"NCT07422506","phase":"NA","title":"A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion","status":"RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2024-01-01","conditions":"Missed Abortion, Early Pregnancy Failure","enrollment":580},{"nctId":"NCT07420010","phase":"EARLY_PHASE1","title":"An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.","status":"NOT_YET_RECRUITING","sponsor":"Weijia Fang, MD","startDate":"2026-03-15","conditions":"Ovarian Cancer, Mesothelioma, Colon Cancer","enrollment":24},{"nctId":"NCT07421895","phase":"","title":"A Prospective Multicenter Observational Real-world Study of Retained Products of Conception","status":"RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2022-06-01","conditions":"Retained Products of Conception, RPOC","enrollment":600},{"nctId":"NCT07406360","phase":"PHASE3","title":"A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age","status":"NOT_YET_RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2026-04-13","conditions":"Measles","enrollment":1209},{"nctId":"NCT07276191","phase":"NA","title":"UL Smile: A Mobile Health Application to Promote Oral Health in Portuguese Adolescents","status":"RECRUITING","sponsor":"University of Lisbon","startDate":"2026-02-02","conditions":"Oral Health Care, Oral Health Behavior Change, Oral Health Self-efficacy","enrollment":150},{"nctId":"NCT06397768","phase":"PHASE3","title":"Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers","status":"TERMINATED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-05-13","conditions":"RSV Immunization","enrollment":2226},{"nctId":"NCT06873334","phase":"PHASE2, PHASE3","title":"Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease","status":"RECRUITING","sponsor":"Skyhawk Therapeutics, Inc.","startDate":"2025-05-27","conditions":"Huntington Disease, Huntingtons Disease","enrollment":120},{"nctId":"NCT04648033","phase":"PHASE1","title":"Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2020-12-07","conditions":"Locally Advanced Non-Small Cell Lung Cancer","enrollment":21},{"nctId":"NCT03412747","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2018-01-26","conditions":"Chronic Plaque Psoriasis, Moderate to Severe Plaque Psoriasis","enrollment":478},{"nctId":"NCT06800261","phase":"PHASE1","title":"Clinical Trial of PCV24 in Infants Aged 2-23 Months","status":"RECRUITING","sponsor":"Sinovac Life Sciences Co., Ltd.","startDate":"2025-05-08","conditions":"Pneumococcal Infectious Disease","enrollment":180},{"nctId":"NCT05573334","phase":"NA","title":"Vaginal Care System for Menopausal Women With Urinary Tract Infections","status":"COMPLETED","sponsor":"Vaginal Biome Science","startDate":"2023-07-10","conditions":"Urinary Tract Infections, Vaginal Flora Imbalance","enrollment":8},{"nctId":"NCT06229288","phase":"PHASE3","title":"Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2024-04-25","conditions":"Community-acquired Pneumonia","enrollment":326},{"nctId":"NCT06647407","phase":"PHASE1, PHASE2","title":"Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-11-05","conditions":"Meningococcal Immunization, Healthy Volunteers","enrollment":750},{"nctId":"NCT07345195","phase":"NA","title":"The Effect of 16-week Dietary Intake of Food Supplements Containing Collagen and MSM on Facial Erythema and Other Skin Parameters","status":"NOT_YET_RECRUITING","sponsor":"VIST - Faculty of Applied Sciences","startDate":"2026-01","conditions":"Erythema, Telangiectasis, Skin Redness","enrollment":90},{"nctId":"NCT07113158","phase":"PHASE3","title":"Effect of Aspirin and Folic Acid for Sudden Sensorineural Hearing Loss","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-04-01","conditions":"Sudden Sensorineural Hearing Loss","enrollment":142},{"nctId":"NCT06799364","phase":"NA","title":"Fermented Dairy Product and Bifidobacterium Diversity (ThreeBees)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Danone Global Research & Innovation Center","startDate":"2025-02-21","conditions":"A03 - Digestive System, B03 - Bacteria","enrollment":182},{"nctId":"NCT06717815","phase":"PHASE1, PHASE2","title":"Phase IIa Study for IPG11406 in Patients With Lupus Nephritis","status":"RECRUITING","sponsor":"Nanjing Immunophage Biotech Co., Ltd","startDate":"2025-02-25","conditions":"Lupus Nephritis","enrollment":36},{"nctId":"NCT06128733","phase":"PHASE1, PHASE2","title":"Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2023-10-31","conditions":"Meningococcal Immunisation, Healthy Volunteers","enrollment":1215},{"nctId":"NCT05497284","phase":"PHASE2","title":"To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2022-11-10","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":46},{"nctId":"NCT07305519","phase":"NA","title":"The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth:","status":"NOT_YET_RECRUITING","sponsor":"University of Roma La Sapienza","startDate":"2026-01-01","conditions":"Preterm Labor","enrollment":150},{"nctId":"NCT06747455","phase":"PHASE3","title":"BCG for Therapeutic Use Phase Ⅲ Clinical Trial","status":"RECRUITING","sponsor":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","startDate":"2025-04-08","conditions":"BCG","enrollment":438},{"nctId":"NCT00874627","phase":"NA","title":"Sublingual Milk Immunotherapy in Children","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-09","conditions":"Cow Milk Allergy","enrollment":51},{"nctId":"NCT07121140","phase":"NA","title":"Home Blood Transfusions","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2025-06-03","conditions":"Hematologic Malignancy, Myelodysplastic Syndromes, Acute Myeloid Leukemia","enrollment":30},{"nctId":"NCT06695910","phase":"PHASE4","title":"Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).","status":"RECRUITING","sponsor":"Samuel Fortin","startDate":"2024-11-06","conditions":"Brain Fog, Cognitive Health","enrollment":48},{"nctId":"NCT07275385","phase":"NA","title":"Advanced Cutaneous Evaluator (ACE): Estimation of Clinical and Economic Impact","status":"COMPLETED","sponsor":"Fundacin Biomedica Galicia Sur","startDate":"2025-03-26","conditions":"Wounds and Injuries, Wound Complication","enrollment":73},{"nctId":"NCT06806137","phase":"PHASE3","title":"A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2025-05-15","conditions":"Chickenpox","enrollment":600},{"nctId":"NCT07178119","phase":"NA","title":"Bridging Technique Validation for Nasolabial Folds JN-BRIDGE-1","status":"RECRUITING","sponsor":"Dr. Joseph M Novoa Libermann","startDate":"2025-11-22","conditions":"Nasolabial Fold Correction, Facial Aging, Skin Rejuvenation","enrollment":60},{"nctId":"NCT06178991","phase":"PHASE3","title":"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2023-12-20","conditions":"Influenza, COVID-19","enrollment":8795},{"nctId":"NCT06855160","phase":"PHASE3","title":"A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2025-04-17","conditions":"Chickenpox","enrollment":900},{"nctId":"NCT06547866","phase":"PHASE2","title":"Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia","status":"NOT_YET_RECRUITING","sponsor":"French Innovative Leukemia Organisation","startDate":"2025-12-01","conditions":"Waldenstrom Macroglobulinemia","enrollment":102},{"nctId":"NCT03528694","phase":"PHASE3","title":"Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2018-05-14","conditions":"Non-muscle-invasive Bladder Cancer","enrollment":1018},{"nctId":"NCT06755892","phase":"NA","title":"The Effect of 16-week Dietary Intake of Food Supplements Containing Collagen and MSM on Skin","status":"COMPLETED","sponsor":"VIST - Faculty of Applied Sciences","startDate":"2025-01-27","conditions":"Dermis Density, Wrinkles, Dermis Thickness","enrollment":139},{"nctId":"NCT05710783","phase":"PHASE2, PHASE3","title":"Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.","status":"COMPLETED","sponsor":"Laboratorio Avi-Mex, S.A. de C.V.","startDate":"2022-11-09","conditions":"SARS-CoV-2 Infection","enrollment":4065},{"nctId":"NCT04142086","phase":"PHASE1","title":"Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2020-01-15","conditions":"Yellow Fever (Healthy Volunteers)","enrollment":73},{"nctId":"NCT07183163","phase":"","title":"The Role of Obesity in Peri-Implant Health(ROPIPH)","status":"COMPLETED","sponsor":"Mine Keskin","startDate":"2023-02-12","conditions":"Obesity &Amp; Overweight, Peri Implantitis, Dental Implant","enrollment":80},{"nctId":"NCT04368429","phase":"PHASE3","title":"Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age","status":"COMPLETED","sponsor":"Sanofi","startDate":"2020-05-22","conditions":"Meningococcal Immunisation (Healthy Volunteers)","enrollment":360},{"nctId":"NCT06175221","phase":"PHASE2","title":"Autologous TLPO Vaccine Basket","status":"TERMINATED","sponsor":"Elios Therapeutics, LLC","startDate":"2023-11-29","conditions":"Tumor, Solid, Tumor Metastasis, Cancer","enrollment":63},{"nctId":"NCT06348719","phase":"NA","title":"Medico-economic Evaluation of Robot-assisted Laparoscopy Compared With Conventional Laparoscopy in Hysterectomy for Endometrial Cancer.","status":"RECRUITING","sponsor":"Rennes University Hospital","startDate":"2024-09-23","conditions":"Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma","enrollment":1680},{"nctId":"NCT06976736","phase":"","title":"A Long Term Follow-up Study of TScan TCR-T Products","status":"RECRUITING","sponsor":"TScan Therapeutics, Inc.","startDate":"2025-09-09","conditions":"AML, ALL, MDS","enrollment":1000},{"nctId":"NCT01810588","phase":"PHASE2","title":"Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2012-10-16","conditions":"Hematologic Malignancies","enrollment":270},{"nctId":"NCT06698666","phase":"PHASE3","title":"Efficacy of Statins Among Major Depressive Disorder","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2022-10-01","conditions":"Major Depressive Disorder, MDD","enrollment":145},{"nctId":"NCT06049927","phase":"PHASE3","title":"A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2023-09-16","conditions":"Seasonal Influenza","enrollment":3300},{"nctId":"NCT07111767","phase":"NA","title":"Effectiveness of a Modified Cost-Effective Dietary Plan in Promoting Weight Loss and Preservation of Lean Body Mass in Patients After Bariatric Surgery","status":"NOT_YET_RECRUITING","sponsor":"Khyber Teaching Hospital","startDate":"2025-10","conditions":"Obesity, Bariatric Surgery, Nutritional Status","enrollment":122},{"nctId":"NCT07090941","phase":"NA","title":"EVT in Acute Basilar Artery Occlusion With Large Infarction Core","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Hainan Medical University","startDate":"2025-08-01","conditions":"Basilar Artery Occlusion, Large Ischemic Core, Large Core Infarct","enrollment":348},{"nctId":"NCT04523688","phase":"PHASE2","title":"Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma","status":"RECRUITING","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2021-03-25","conditions":"Glioblastoma, Vaccination","enrollment":28},{"nctId":"NCT07063875","phase":"PHASE1, PHASE2","title":"Adding IL-2 to Tebentafusp to Eradicate Cancer Progression","status":"RECRUITING","sponsor":"St Vincent's Hospital, Sydney","startDate":"2025-06-01","conditions":"Uveal Melanoma, Metastatic Uveal Melanoma, Metastatic Uveal Melanoma in the Liver","enrollment":8},{"nctId":"NCT06777498","phase":"NA","title":"The Precision Nutrition New York Study","status":"RECRUITING","sponsor":"Cornell University","startDate":"2025-01-13","conditions":"Body Composition Changes, Body Weight Changes","enrollment":15},{"nctId":"NCT06892834","phase":"PHASE2","title":"Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control.","status":"COMPLETED","sponsor":"Procter and Gamble","startDate":"2025-03-25","conditions":"Gingivitis","enrollment":120},{"nctId":"NCT07038577","phase":"NA","title":"Impact of Fenugreek Supplementation on Obesity and Hyperglycemia Among Diabetic Adults in Saudi Arabia","status":"COMPLETED","sponsor":"University of Hail","startDate":"2025-01-01","conditions":"Type 2 Diabetes Mellitus (T2DM), Obesity and Type 2 Diabetes, Hyperglycemia","enrollment":80},{"nctId":"NCT06955819","phase":"NA","title":"GUTPROH: Probiotic-Herbal Formula for Self-Reported Constipation in Community Adults","status":"NOT_YET_RECRUITING","sponsor":"Beijing Hospital","startDate":"2025-07-10","conditions":"Functional Constipation (FC)","enrollment":300},{"nctId":"NCT07015307","phase":"NA","title":"Sustainable Exercise and Nutrition Programs for Managing Metabolic Disorders in Older Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alicante","startDate":"2025-06-01","conditions":"Metabolic Syndrome, Aging, Sarcopenia","enrollment":140},{"nctId":"NCT06150898","phase":"PHASE2","title":"Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)","status":"RECRUITING","sponsor":"Jules Bordet Institute","startDate":"2025-05-12","conditions":"Early-stage Breast Cancer, Estrogen-receptor-positive Breast Cancer","enrollment":112},{"nctId":"NCT07017127","phase":"NA","title":"Remission of Type 2 Diabetes With Lifestyle Intervention","status":"RECRUITING","sponsor":"University of Split, School of Medicine","startDate":"2025-05-01","conditions":"Diabetes Mellitus Type 2, Obese Diabetics","enrollment":120},{"nctId":"NCT06985745","phase":"NA","title":"Emulsion 8-Week Anti-acne Efficacy Clinical Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"ChinaNorm","startDate":"2025-03-08","conditions":"Female, Male, Acne","enrollment":66},{"nctId":"NCT06438744","phase":"NA","title":"The Role of Thread Embedding Acupuncture for Pain and Quality of Life in Endometriosis Patients","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2023-12-18","conditions":"Endometriosis-related Pain","enrollment":10},{"nctId":"NCT05525858","phase":"","title":"KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II","status":"RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2022-09-28","conditions":"Solid Tumor, Advanced Solid Tumor, Metastatic Cancer","enrollment":1000},{"nctId":"NCT04404400","phase":"PHASE3","title":"Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-02-17","conditions":"Critical Illness Related Corticosteroids Insufficiency","enrollment":1092},{"nctId":"NCT06474377","phase":"PHASE1","title":"Clinical Trial of PCV24 in Adults","status":"COMPLETED","sponsor":"Sinovac Life Sciences Co., Ltd.","startDate":"2024-06-21","conditions":"Pneumococcal Infectious Disease","enrollment":170},{"nctId":"NCT06930365","phase":"NA","title":"Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products In Atopic Dermatitis","status":"RECRUITING","sponsor":"NAOS Les Laboratoires","startDate":"2024-12-09","conditions":"Atopic Dermatitis, Eczema","enrollment":64},{"nctId":"NCT06924736","phase":"NA","title":"SONICURE（SONICracker for the Treatment of UndeRExpansion）","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Bluesail Boyuan Medical Technology Co., Ltd.","startDate":"2025-05-15","conditions":"Coronary Artery Disease","enrollment":200},{"nctId":"NCT05384015","phase":"PHASE2","title":"Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Fundación GECP","startDate":"2022-11-07","conditions":"Small Cell Lung Cancer Extensive Stage","enrollment":46},{"nctId":"NCT05968768","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)","status":"RECRUITING","sponsor":"Anna Raciborska","startDate":"2023-10-24","conditions":"Ewing Sarcoma","enrollment":24},{"nctId":"NCT06650956","phase":"NA","title":"Integration to Improve Adolescent Health and HPV Vaccination in Laos","status":"RECRUITING","sponsor":"Health Poverty Action","startDate":"2024-11-01","conditions":"Healthy, Adolescents, Integrated, Community-Health Systems","enrollment":700},{"nctId":"NCT06851832","phase":"PHASE1, PHASE2","title":"Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older","status":"RECRUITING","sponsor":"Ab&B Bio-tech Co., Ltd.JS","startDate":"2025-02-16","conditions":"Herpes Zoster, Herpes Zoster Vaccine","enrollment":960},{"nctId":"NCT06352866","phase":"PHASE2","title":"Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM","status":"WITHDRAWN","sponsor":"Jack Khouri, MD","startDate":"2025-01-01","conditions":"Multiple Myeloma, Cytokine Release Syndrome, Refractory Multiple Myeloma","enrollment":""},{"nctId":"NCT05976139","phase":"NA","title":"Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies","status":"RECRUITING","sponsor":"Fondazione G.B. Bietti, IRCCS","startDate":"2023-09-06","conditions":"Macular Edema, Inherited Retinal Dystrophy, Laser Retinopathy","enrollment":10},{"nctId":"NCT03556592","phase":"PHASE1","title":"Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2018-08-13","conditions":"Atopic Dermatitis","enrollment":40},{"nctId":"NCT05789615","phase":"","title":"Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2023-04-01","conditions":"CMV Infection, Hematopoietic Stem Cell Transplantation","enrollment":200},{"nctId":"NCT04332926","phase":"NA","title":"Effects of E-Cigarette Nicotine Content in Smokers (Nicotine Flux Study)","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2021-01-05","conditions":"Electronic Cigarette Use","enrollment":44},{"nctId":"NCT06818630","phase":"NA","title":"Enhanced Photoaging Reversal Efficacy and Safety of 755nm Alexandrite Picosecond Laser with Diffractive Lens Array (DLA) in Conjunction with Integrated Skin Care for Skin Quality Improvement","status":"COMPLETED","sponsor":"L'Oréal Taiwan Co., Ltd","startDate":"2024-07-29","conditions":"Skin Quality Improvement","enrollment":35},{"nctId":"NCT05700877","phase":"PHASE4","title":"Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes","status":"RECRUITING","sponsor":"Per Løgstrup Poulsen","startDate":"2023-01-12","conditions":"Type 2 Diabetes, Cardiovascular Diseases","enrollment":7300},{"nctId":"NCT04143061","phase":"PHASE3","title":"Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2019-12-30","conditions":"Meningococcal Immunization, Healthy Volunteers","enrollment":1328},{"nctId":"NCT05499377","phase":"NA","title":"The Abuse Liability of a Novel Heated Tobacco Product (IQOS) and Its Feasibility as a Menthol Cigarette Substitute","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2022-11-28","conditions":"Tobacco Use","enrollment":33},{"nctId":"NCT06789471","phase":"NA","title":"The Effects of Psyllium Seed on Body Weight and Metabolic Syndrome Indicators in Patients with Schizophrenia","status":"COMPLETED","sponsor":"Ru-Shin Zhang","startDate":"2024-05-01","conditions":"Overweight and Obesity, Metabolic Cardiovascular Syndrome, Schizophrenia, Disorganized","enrollment":24},{"nctId":"NCT02465268","phase":"PHASE2","title":"Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme","status":"COMPLETED","sponsor":"University of Florida","startDate":"2016-08-09","conditions":"Glioblastoma Multiforme, Glioblastoma, Malignant Glioma","enrollment":175},{"nctId":"NCT05492318","phase":"PHASE1","title":"Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity","status":"COMPLETED","sponsor":"Italfarmaco","startDate":"2022-03-21","conditions":"Drug-Drug Interaction, Heathy Volunteer","enrollment":26},{"nctId":"NCT06607172","phase":"PHASE3","title":"Clinical Efficacy of the Combined Effect of Oral Irrigator and Chemicals (0.075% CPC)","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2024-09-30","conditions":"Dental Plaque, Dental Plaque Induced Gingivitis, Dental Plaque and Gingivitis","enrollment":30},{"nctId":"NCT03799835","phase":"PHASE3","title":"Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2019-01-17","conditions":"Bladder Cancer","enrollment":517},{"nctId":"NCT06720077","phase":"NA","title":"Effect of Acupressure in The Management of Postmenopausal Constipation","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2024-12-07","conditions":"Constipation","enrollment":60},{"nctId":"NCT06441955","phase":"PHASE4","title":"Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.","status":"RECRUITING","sponsor":"Well- Konnect Healthcare Services and Research Firm","startDate":"2024-03-01","conditions":"COVID-19, Long Haul","enrollment":100},{"nctId":"NCT03204357","phase":"NA","title":"Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-01-24","conditions":"Cardiac Disease, Bleeding Postoperative","enrollment":70},{"nctId":"NCT05515874","phase":"PHASE4","title":"Predicting Stroke Risk in ICAD With Novel MRI","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2021-08-16","conditions":"Intracranial Atherosclerosis","enrollment":100},{"nctId":"NCT05993325","phase":"PHASE3","title":"Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cellid Co., Ltd.","startDate":"2023-11-27","conditions":"COVID-19, Vaccines","enrollment":4000},{"nctId":"NCT06686043","phase":"PHASE2","title":"HPV Vaccine, Imiquimod, and Metformin Combination Trial","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2024-08-23","conditions":"Cervical Carcinoma, Vaginal Carcinoma, Vulvar Carcinoma","enrollment":85},{"nctId":"NCT06651437","phase":"NA","title":"Salt Consumption After the Administration of Rapid Questionnaire (MINISAL-SIIA STUDY)","status":"COMPLETED","sponsor":"Prof. Ferruccio Galletti","startDate":"2016-07-01","conditions":"Hypertension","enrollment":315},{"nctId":"NCT03603795","phase":"PHASE2","title":"Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"French Innovative Leukemia Organisation","startDate":"2018-10-11","conditions":"Acute Myeloid Leukemia","enrollment":110},{"nctId":"NCT05584137","phase":"PHASE2","title":"Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients with MCRC","status":"TERMINATED","sponsor":"Shanghai Henlius Biotech","startDate":"2023-06-15","conditions":"Colorectal Cancer Metastatic","enrollment":2},{"nctId":"NCT04667117","phase":"PHASE4","title":"A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-01-14","conditions":"Relapsing Multiple Sclerosis","enrollment":63}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Investigational products administration","genericName":"Investigational products administration","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is an investigational product that targets the PD-1/PD-L1 pathway. Used for Metastatic non-small cell lung cancer, PD-L1 positive, Metastatic melanoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}